News
Glox Therapeutics awarded share of £3m Collaborative Discovery Programme funding from Cystic Fibrosis Antimicrobial...
Glox Therapeutics, a company developing precision antibiotic therapies based on naturally occurring bacteriocins, has been awarded a share of the £3 million Collaborative Discovery...
Pioneer Group drives AI innovation in healthcare through industry and academic collaboration
Pioneer Group, the life science infrastructure and venture building specialist, has joined forces with Innovate UK, The Medical Research Council (MRC) and AstraZeneca, to...
FDA approves LUMAKRAS in combination with Vectibix for chemorefractory KRAS G12C-mutated metastatic colorectal cancer
The U.S. Food and Drug Administration (FDA) has approved Amgen's LUMAKRAS (sotorasib) in combination with Vectibix (panitumumab) for the treatment of adult patients with KRAS G12C-mutated...
